HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Parathyroid carcinoma.

AbstractBACKGROUND:
Parathyroid carcinoma is a rare malignancy affecting 0.5-5 per cent of all patients with primary hyperparathyroidism. This article reviews the literature on the pathogenesis, pathology, clinical features, diagnosis and management of parathyroid carcinoma.
METHODS:
A Medline search was performed and all relevant English language articles published between 1970 and 2005 were retrieved. The search words included 'parathyroid carcinoma', 'pathology', 'genetics', 'management' and 'radiotherapy'. Secondary references were obtained from key articles.
RESULTS AND CONCLUSION:
The exact aetiology of parathyroid carcinoma remains obscure. Recently, the HRPT2 gene has been implicated in its pathogenesis and may prove to be a genetic target in future. Surgical resection is the accepted 'gold standard'. There is now a growing consensus on the use of adjuvant radiotherapy as it has been shown to provide a survival benefit.
AuthorsN Rawat, N Khetan, D W Williams, J N Baxter
JournalThe British journal of surgery (Br J Surg) Vol. 92 Issue 11 Pg. 1345-53 (Nov 2005) ISSN: 0007-1323 [Print] England
PMID16237743 (Publication Type: Journal Article, Review)
Topics
  • Combined Modality Therapy
  • Humans
  • Neoplasm Recurrence, Local (therapy)
  • Parathyroid Neoplasms (diagnosis, etiology, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: